Highly substituted and stereochemically defined borylated cyclobutanes and derivatives

Overview

This solution presents a novel synthetic methodology for producing highly substituted and stereochemically defined borylated cyclobutanes. The approach uses a new cyclization strategy that delivers borylated cyclobutanols with precise control over substitution patterns and stereochemistry. These intermediates carry two versatile functional handles—a boron group and an alcohol—that can be independently derivatized to access a broad range of cyclobutane-based molecular scaffolds. Cyclobutane rings are increasingly important in pharmaceutical research as bioisosteres (structural mimics of functional groups) for aromatic rings, offering improved metabolic stability and novel three-dimensional geometry in drug candidates.

Technical specifications

Key features:

• New cyclization strategy for building highly substituted cyclobutane rings
• Stereochemically defined borylated cyclobutanols produced in a single chemistry-driven transformation
• Dual functional handles (boron and alcohol) enabling further derivatization
• Modular approach supporting the generation of diverse cyclobutane-based scaffolds
• Applicable to medicinal chemistry, agrochemical, and materials science research

How it works:

The methodology centers on a cyclization reaction that installs both a boron substituent and a hydroxyl group on a four-membered carbocyclic ring (cyclobutane) with defined stereochemistry. The resulting borylated cyclobutanols can then undergo downstream transformations through either the C–B bond (such as oxidation, cross-coupling, or homologation) or the alcohol handle (such as substitution, oxidation, or esterification), giving researchers flexible routes to target molecules.

Technology readiness level

The synthetic strategy has been demonstrated in the laboratory, with borylated cyclobutanols successfully produced and characterized. Further validation of the scope, derivatization pathways, and potential applications is ongoing. The technology is positioned for collaborative development with industry partners interested in novel synthetic routes to strained-ring building blocks for pharmaceutical and specialty chemical applications.